abnormal gene silencing may lead to breast cancer progression

Emory University scientists have discovered that a mistake in the way DNA is labeled and packaged by methyltransferase enzymes could lead to the abnormal silencing of TMS-1, a gene that plays an important role in keeping breast cancer cells in check, thus contributing to breast cancer progression.

Contact:
Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University Health Sciences Center

Message posted by: Wouter Kalle